p36 is a calcium/lipid-binding phosphoprotein that is expressed at hig
h levels in proliferating and transformed cells, and at low levels in
terminally differentiated cells, such as CNS neurons. The calcium-depe
ndent binding to membrane phospholipids, and its capacity to interact
with intermediate filament proteins suggest that p36 may be involved i
n the transduction of extracellular signals. The present work examines
p36 gene expression in the mature CNS, primary primitive neuroectoder
mal tumors (PNETs), and transformed PNET cell lines. p36 immunoreactiv
ity was not observed in normal adult human brain, but low levels of th
e protein were detected by Western blot analysis. Following acute anox
ic cerebral injury, the mean levels of p36 protein were elevated two-f
old, and injured neurons exhibited increased p36 immunoreactivity. Thi
s phenomenon was likely to have been mediated by post-transcriptional
mechanisms since there was no corresponding change in the level p36 mR
NA. p36 immunoreactivity was detected in 8 of 9 primary PNETs, and in
3 of 3 neurofilament-expressing PNET cell lines. The levels of p36 pro
tein in PNET cell lines were 5-fold higher than in adult human brain t
issue. Although p36 gene expression was generally high in proliferatin
g PNET cells, the levels of p36 mRNA and protein were not strictly cor
related with DNA synthesis. Instead, p36 gene expression was modulated
in both proliferating and non-proliferating PNET cell cultures by tre
atment with 50 mIU/ml of insulin, 100 mM ethanol, or 5 mu M retinoic a
cid. The frequent discordances observed experimentally and in vivo bet
ween p36 mRNA and p36 protein expression suggest that the steady-state
levels of p36 protein in neuronal cells may be regulated primarily by
post-transcriptional mechanisms.